Steven,

In the October 16th, 2017 news release, the following statement can be read in regards to Gen2 and Gen3:

"This phase of testing, expected to last several weeks is important as it will give us crucial data to commence final design of the PUREVAPtm Pilot Plant to be constructed in 2018."

I think it's safe to say that the Pilot Plant (Gen3) wont be finished this month as per the Gantt chart.

But like you Steven, I also would like to have a better idea of expected timelines.  And I've heard Bernard say a couple of times now he doesn't like to give timelines because when they are missed he gets "crucified".  I would like to argue that time estimates should still be offered, otherwise there will never be a sense of urgency to buy stock in this company.  For the share price to go up, or to not slide further, people need to see hard targets and timelines offered, even if they do get missed.  Otherwise, fickle venture investors will just put their money somewhere else and come back later.

Duff.